Search Results
Search for other papers by Andrea Perra in
Google Scholar
PubMed
Search for other papers by Michelina Plateroti in
Google Scholar
PubMed
Search for other papers by Amedeo Columbano in
Google Scholar
PubMed
. (2010) Hepatocellular carcinoma Rat ↓ mRNA levels (qRT-PCR) Frau et al . (2015) Hepatocellular carcinoma Rat ↓ protein levels (WB) Frau et al . (2015) TRs alterations and HCC Hepatocellular carcinoma (HCC) is
Search for other papers by Hidewaki Nakagawa in
Google Scholar
PubMed
). In particular, Asian populations have a substantially lower incidence rate than Caucasians or African Americans, indicating the contribution of different genetic backgrounds to PC susceptibility ( Gronberg 2003 , Schaid 2004 , Nakagawa et al . 2012
Search for other papers by A Garolla in
Google Scholar
PubMed
Search for other papers by A Ferlin in
Google Scholar
PubMed
Search for other papers by C Vinanzi in
Google Scholar
PubMed
Search for other papers by A Roverato in
Google Scholar
PubMed
Search for other papers by G Sotti in
Google Scholar
PubMed
Search for other papers by W Artibani in
Google Scholar
PubMed
Search for other papers by C Foresta in
Google Scholar
PubMed
identified and probably other TGCT putative genes exist. Recently, other suggestions of a genetic basis for TC ( Chemes et al. 2003 , Skakkebæk et al. 2003 ) have been made; however, specific genetic alterations including genetic susceptibility to
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Trisha Dwight in
Google Scholar
PubMed
Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark
Search for other papers by Aidan Flynn in
Google Scholar
PubMed
Search for other papers by Kaushalya Amarasinghe in
Google Scholar
PubMed
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Diana E Benn in
Google Scholar
PubMed
Search for other papers by Richard Lupat in
Google Scholar
PubMed
Search for other papers by Jason Li in
Google Scholar
PubMed
Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Daniel L Cameron in
Google Scholar
PubMed
Search for other papers by Annette Hogg in
Google Scholar
PubMed
Search for other papers by Shiva Balachander in
Google Scholar
PubMed
The Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Ida L M Candiloro in
Google Scholar
PubMed
Search for other papers by Stephen Q Wong in
Google Scholar
PubMed
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Bruce G Robinson in
Google Scholar
PubMed
Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
The Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Anthony T Papenfuss in
Google Scholar
PubMed
Cancer Diagnosis and Pathology Group, Kolling Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Anthony J Gill in
Google Scholar
PubMed
The Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia
Search for other papers by Alexander Dobrovic in
Google Scholar
PubMed
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Rodney J Hicks in
Google Scholar
PubMed
The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
The Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Richard W Tothill in
Google Scholar
PubMed
the adrenal medulla. Although rare, they often occur as part of hereditary endocrine tumor syndromes and their study has been richly rewarding for identifying genetic events that drive tumorigenesis ( Castro-Vega et al . 2015 a ). Metastatic disease
Section of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
Search for other papers by T Vandamme in
Google Scholar
PubMed
Search for other papers by M Beyens in
Google Scholar
PubMed
Search for other papers by G Boons in
Google Scholar
PubMed
Search for other papers by A Schepers in
Google Scholar
PubMed
Search for other papers by K Kamp in
Google Scholar
PubMed
Search for other papers by K Biermann in
Google Scholar
PubMed
Search for other papers by P Pauwels in
Google Scholar
PubMed
Search for other papers by W W De Herder in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by M Peeters in
Google Scholar
PubMed
Search for other papers by G Van Camp in
Google Scholar
PubMed
Search for other papers by K Op de Beeck in
Google Scholar
PubMed
reached). Genetic alterations in pNENs Targeted resequencing of the selected HaloPlex enrichment 20-gene panel (see Materials and methods) resulted in a total of 416,711,794 reads, passing quality filtering, across 38 tumor samples and three normal
Search for other papers by Rachel Pimenta Riechelmann in
Google Scholar
PubMed
Search for other papers by Mauro Daniel Spina Donadio in
Google Scholar
PubMed
Search for other papers by Victor Hugo Fonseca de Jesus in
Google Scholar
PubMed
Search for other papers by Nathalia de Angelis de Carvalho in
Google Scholar
PubMed
Search for other papers by Karina Miranda Santiago in
Google Scholar
PubMed
Search for other papers by Milton J Barros in
Google Scholar
PubMed
Search for other papers by Laura Lopes in
Google Scholar
PubMed
Search for other papers by Gabriel Oliveira dos Santos in
Google Scholar
PubMed
Department of Oncogenetics, A.C. Camargo Cancer Center, São Paulo, Brazil
Search for other papers by Maria Nirvana Formiga in
Google Scholar
PubMed
National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation (INCITO-INOTE), São Paulo, Brazil
Search for other papers by Dirce Maria Carraro in
Google Scholar
PubMed
National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation (INCITO-INOTE), São Paulo, Brazil
Search for other papers by Giovana Tardin Torrezan in
Google Scholar
PubMed
non-Hodgkin lymphoma ( Neklason et al. 2016 ). While the carcinogenic mechanisms involved in NENs remain obscure, these studies point to inherited genetic alterations underlying NEN development. However, research performed in NENs beyond well
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Bruno Ragazzon in
Google Scholar
PubMed
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
from the paternal allele, and H19 and CDKN1C are expressed from the maternal allele. In BWS, various genetic and epigenetic alterations are associated with the overexpression of IGF2 , as well as with the low expression of CDKN1C and H19 ( Lam
Search for other papers by Cristina Romei in
Google Scholar
PubMed
Search for other papers by Raffaele Ciampi in
Google Scholar
PubMed
Search for other papers by Pinuccia Faviana in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Paolo Miccoli in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Departments of, Endocrinology and Metabolism, Oncology, Surgery, Department of Internal Medicine, AMBISEN Center, University of Pisa, 56100 Pisa, Italy
Search for other papers by Aldo Pinchera in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
associated with the more aggressive phenotype, no clear correlation between RET/PTC rearrangements and a better or worse prognosis has been documented ( Basolo et al . 2001 ). The V600E mutation is the only BRAF genetic alteration (BRAF V600E ) consistently
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Marina Muzza in
Google Scholar
PubMed
Search for other papers by Gabriele Pogliaghi in
Google Scholar
PubMed
Search for other papers by Sonia Palazzo in
Google Scholar
PubMed
Search for other papers by Guia Vannucchi in
Google Scholar
PubMed
Search for other papers by Leonardo Vicentini in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Search for other papers by Giacomo Gazzano in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
alterations found in TC (reviewed in Muzza et al. 2020 ). We recently developed a PTC-MA assay that able to evaluate in an extremely cost-effective manner (300 euro/sample), a total of 24 genetic alterations including point mutations and fusions frequently
Search for other papers by Y M H Jonkers in
Google Scholar
PubMed
Search for other papers by S M H Claessen in
Google Scholar
PubMed
Search for other papers by A Perren in
Google Scholar
PubMed
Search for other papers by S Schmid in
Google Scholar
PubMed
Search for other papers by P Komminoth in
Google Scholar
PubMed
Search for other papers by A A Verhofstad in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by R R de Krijger in
Google Scholar
PubMed
Search for other papers by P J Slootweg in
Google Scholar
PubMed
Search for other papers by F C S Ramaekers in
Google Scholar
PubMed
Search for other papers by E-J M Speel in
Google Scholar
PubMed
alterations, always ≥3 copies of the 9q34-specific region were observed including two cases with an amplification (patients 10 and 15). Four cases showed tumor subpopulations with aberrant copy numbers of chromosome 9 targets indicating genetic heterogeneity